High Prevalence of Anti–Severe Acute Respiratory Syndrome Coronavirus 2 (Anti–SARS-CoV-2) Antibodies After the First Wave of Coronavirus Disease 2019 (COVID-19) in Kinshasa, Democratic Republic of the Congo: Results of a Cross-sectional Household-Based Survey

High Prevalence of Anti–Severe Acute Respiratory Syndrome Coronavirus 2 (Anti–SARS-CoV-2) Antibodies After the First Wave of Coronavirus Disease 2019 (COVID-19) in Kinshasa, Democratic Republic of the Congo: Results of a Cross-sectional Household-Based Survey

Nkuba, Antoine N;Makiala, Sheila M;Guichet, Emilande;Tshiminyi, Paul M;Bazitama, Yannick M;Yambayamba, Marc K;Kazenza, Benito M;Kabeya, Trésor M;Matungulu, Elysee B;Baketana, Lionel K;Mitongo, Naomi M;Thaurignac, Guillaume;Leendertz, Fabian H;Vanlerberghe, Veerle;Pelloquin, Raphaël;Etard, Jean-François;Maman, David;Mbala, Placide K;Ayouba, Ahidjo;Peeters, Martine;Muyembe, Jean-Jacques T;Delaporte, Eric;Ahuka, Steve M;
clinical infectious diseases pp. -
138
nclinicalhigh

Abstract

Despite the early containment measures of the DRC government, the COVID-19 pandemic has spread in Kinshasa with an overall 16.6% SARS-CoV-2 seroprevalence after

Keywords

Citation

ID: 270518
Ref Key: nclinicalhigh
Use this key to autocite in SciMatic or Thesis Manager

References

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
270518
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
4/5
Blockchain Upload Locked

Complete all 5 checklist items to tokenize your article

Saymatik Web3.0 Wallet